All products / DC23213
SCIO-469
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $500 USDRequest a quote → |
| 250 mg | $1,000 USDRequest a quote → |
| 1 g | $2,000 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
A potent, selective p38α MAPK inhibitor with IC50 of 9 nM; displays 10-fold selectivity for p38α over p38β, >2,000-fold selectivity over a panel of 20 other kinases, including other MAP kinases; decreases apoptosis in MDS CD34+ progenitors and leads to dose-dependant increases in erythroid and myeloid colony formation; enhances the ability of MG132 and bortezomib to induce the apoptosis of MM cells, and inhibits tumor growth in vivo.Rheumatoid ArthritisPhase 2 Discontinued
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC23213 |
|---|---|
| Product name | SCIO-469 |
| CAS | 309913-83-5 |
| Molecular formula | C27H30ClFN4O3 |
| Molecular weight | 513 |
| Purity | >98% |
| SMILES | FC1C=CC(CN2C[C@@H](C)N(C(C3=C(Cl)C=C4C(C(C(C(N(C)C)=O)=O)=CN4C)=C3)=O)C[C@@H]2C)=CC=1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — SCIO-469 (DC23213)